The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Gastrointestinal

BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for IBD
Finance

BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for IBD

SEP 3, 2020
IPA response to 2020 AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders
Biotics and Supplements

IPA response to 2020 AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders

JUN 30, 2020
New microbiome research of practical value to patients
Gastrointestinal

New microbiome research of practical value to patients

JUN 16, 2020
Debiopharm’s Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders
Finance

Debiopharm’s Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders

JUN 10, 2020
Gilead Sciences & Second Genome Announce Strategic Collaboration in Biomarker and IBD Drug Discovery
Finance

Gilead Sciences & Second Genome Announce Strategic Collaboration in Biomarker and IBD Drug Discovery

APR 7, 2020
A common gut microbe secretes a carcinogen
Editor's Choice

A common gut microbe secretes a carcinogen

APR 4, 2020
Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS
Gastrointestinal

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

APR 3, 2020
Ilya Pharma receives BIO-X® grant to complete preclinical work for novel IBD chemokine-based gene therapy candidates
Finance

Ilya Pharma receives BIO-X® grant to complete preclinical work for novel IBD chemokine-based gene therapy candidates

MAR 30, 2020
Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
Gastrointestinal

Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test

DEC 17, 2019
Beware probiotics in ICU patients
Biotics and Supplements

Beware probiotics in ICU patients

NOV 20, 2019
Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?
Biotics and Supplements

Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?

NOV 19, 2019